million. The hospital and service revenues grew by 1.26% comprising 1.41% decrease of existing hospital operation and 25.56% increase of service revenues from the subsidiary (Asia Medical & Agricultural
Rich Asia Corporation Public Company Limited and subsidiaries would like to clarify the results of the year ended June 30, 2018 according to the regulation of The Stock Exchange of Thailand as follow: 1
booked in year 2018 for chronic diseases were then subtracted accordingly. However, the service revenues (mainly received from Asia Medical and Agricultural Laboratory and Research Center Co., Ltd “AMARC
COMPANY LIMITED AMATA VN PUBLIC COMPANY LIMITED AMR ASIA PUBLIC COMPANY LIMITED ANANDA DEVELOPMENT PUBLIC COMPANY LIMITED AP (THAILAND) PUBLIC COMPANY LIMITED APEX DEVELOPMENT PUBLIC COMPANY LIMITED